For example, the presence of high-risk TP53 mutations (identified with the Evolutionary Action (EA) scoring system)66 or higher intra-tumor genetic heterogeneity (scored with the mutant allele tumor heterogeneity (MATH) system)67 offers exciting perspectives for the identification of aggressive OSCC. Here, TP53 is linked to neoplasm.